Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Molecular Diagnostics : JMD|July 13, 2015
Oligonucleotide PIK3CA/Chromosome 3 Dual in Situ Hybridization Automated Assay with Improved Signals, One-Hour Hybridization, and No Use of Blocking DNAWenjun Zhang, Antony Hubbard, Leslie Baca-Parkinson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 20, 2014
The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathwaysTatyana Isayeva, Jie Xu, Camille Ragin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasTanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Leukemia & Lymphoma|November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trialsMichael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
JNCI Cancer Spectrum|July 31, 2019
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic LeukemiaStefania Galimberti, Meenakshi Devidas, Ausiliatrice Lucenti, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 17, 2015
Working to Eliminate Cancer Health Disparities from Tobacco: A Review of the National Cancer Institute's Community Networks ProgramElisa K Tong, Pebbles Fagan, Leslie Cooper, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Frontiers in Cardiovascular Medicine|September 19, 2022
Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery diseaseThomas Stuckey, Frederick Meine, Thomas McMinn, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Head and Neck Pathology|December 20, 2012
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinomaYufeng Li, Shuting Bai, William Carroll, et al.
Pageof 12